Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Eli Lilly completes acquisition of Verve Therapeutics
19h ago
LLY
VERV
Premium
The Fly
Eli Lilly receives CHMP opinion recommending donanemab for Alzheimer’s
22h ago
LLY
Premium
The Fly
Eli Lilly and Verve Therapeutics announce expiration of Verve tender offer
2d ago
LLY
VERV
Premium
The Fly
Roche receives CE Mark for Elecsys pTau181
3d ago
LLY
CHRO
Premium
Ratings
Eli Lilly’s Strategic Advantage in GLP-1RAs and Alzheimer’s Markets Fuels Buy Rating
5d ago
LLY
Premium
Ratings
Eli Lilly & Co: Promising Growth Prospects and Strategic Positioning Amid Competitive Pressures
8d ago
LLY
Premium
The Fly
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
10d ago
MU
AMD
Premium
The Fly
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
15d ago
AZN
BMY
Premium
The Fly
Eli Lilly price target raised to $1,135 from $1,133 at Morgan Stanley
16d ago
LLY
Premium
The Fly
Eli Lilly announces FDA approval of label update for Kisunla
17d ago
LLY
Premium
Ratings
Eli Lilly & Co: Strong Growth Potential and Strategic Market Positioning Justify Buy Rating
17d ago
LLY
Premium
The Fly
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
18d ago
AZN
BMY
Premium
The Fly
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
18d ago
AZN
BMY
Premium
Ratings
Positive Outlook for Eli Lilly & Co Driven by Strong Product Performance and International Growth
18d ago
LLY
Premium
Ratings
Eli Lilly & Co: Strong Growth Potential and Strategic Positioning Justify Buy Rating
19d ago
LLY
Premium
The Fly
Novo Nordisk misread U.S. market for weight loss drug, Reuters reports
25d ago
LLY
NVO
Premium
The Fly
Health officials met with Walmart, Amazon on DTP drug sales, Bloomberg says
26d ago
LLY
WMT
Premium
The Fly
Trump Trade: Canada rescinds digital services tax after U.S. drops trade talks
26d ago
MP
NB
Premium
The Fly
Verve Therapeutics downgraded to Market Perform from Outperform at BMO Capital
29d ago
LLY
VERV
Premium
The Fly
Crispr posts strong CTX310 data, says Chardan
30d ago
LLY
CRSP
Premium
The Fly
Citi sees tiered orforglipron pricing $15B opportunity for Eli Lilly
1M ago
LLY
NVO
Premium
The Fly
Eli Lilly treatment of KRAS G12C-mutant NSCLC granted orphan designation
1M ago
LLY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
